Literature DB >> 3491640

Regulation of early human hematopoietic (BFU-E and CFU-GEMM) progenitor cells in vitro by interleukin 1-induced fibroblast-conditioned medium.

J R Zucali, H E Broxmeyer, C A Dinarello, M A Gross, R S Weiner.   

Abstract

Stimulators of human erythroid burst-forming units (BFU-E) and multipotential colony-forming cells (CFU-GEMM) can be produced by a number of different cell types. A product of human peripheral blood monocytes, interleukin 1 (IL-1), was evaluated for its ability to stimulate fibroblast cultures to produce stimulators of human bone marrow BFU-E and CFU-GEMM colony formation. BFU-E and CFU-GEMM colony formation was evaluated using low-density, nonadherent low-density, and T lymphocyte-depleted nonadherent low-density human bone marrow cells cultured in the presence of a source of pure human erythropoietin. Both human monocyte conditioned medium (MCM) and human recombinant IL-1 (hrIL-1) induced fibroblasts to produce stimulators of BFU-E and CFU-GEMM in a dose-dependent fashion with maximal colony formation occurring when fibroblasts were stimulated by 25% MCM or 140 ng/mL ROO6B hrIL-1, or 1.25 to 5 ng/mL ROO6T hrIL-1. Preincubation of MCM and hrIL-1 with an antibody to IL-1 inactivated the ability of MCM and hrIL-1 to induce the release of erythroid and multipotential colony stimulating activity from fibroblasts. These results suggest that monocyte-derived IL-1 is involved in regulating the production of humoral stimulators of early human hematopoietic progenitors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3491640

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Protracted anemia associated with chronic, relapsing systemic inflammation induced by arthropathic peptidoglycan-polysaccharide polymers in rats.

Authors:  R B Sartor; S K Anderle; N Rifai; D A Goo; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

2.  Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin.

Authors:  H E Broxmeyer; L Lu; S Cooper; R H Schwall; A J Mason; K Nikolics
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Response of simian virus 40 (SV40)-transformed, cultured human marrow stromal cells to hematopoietic growth factors.

Authors:  J Nemunaitis; D F Andrews; C Crittenden; K Kaushansky; J W Singer
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

4.  An assessment of myeloid colony-forming-cell generation in liquid human bone marrow cultures: influence of accessory cells and cytokines IL-1 alpha, beta and IL-6.

Authors:  R P Gooding; P G Riches; M Y Gordon
Journal:  Int J Exp Pathol       Date:  1993-04       Impact factor: 1.925

Review 5.  Early circulating erythroid progenitors (BFU-E) in sickle cell anemia.

Authors:  H Croizat
Journal:  Experientia       Date:  1993-02-15

6.  Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor 1, recombinant murine interleukin 3, and recombinant murine granulocyte/macrophage colony-stimulating factor.

Authors:  H E Broxmeyer; D E Williams; G Hangoc; S Cooper; S Gillis; R K Shadduck; D C Bicknell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

Review 7.  The biological activities of interleukin-1.

Authors:  W E Fibbe; M R Schaafsma; J H Falkenburg; R Willemze
Journal:  Blut       Date:  1989-08

8.  Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor.

Authors:  N Bilyk; P G Holt
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

9.  Interleukin 1 enhances growth factor-dependent proliferation of the clonogenic cells in acute myeloblastic leukemia and of normal human primitive hemopoietic precursors.

Authors:  T Hoang; A Haman; O Goncalves; F Letendre; M Mathieu; G G Wong; S C Clark
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.